Opticyte logo

Opticyte

Preventing Organ Failure Through Early Detection. Join our crowdfunding campaign today on StartEngine!

8 employees · est. 2016 · Seattle, United States

VS
Spectral Medical Inc. logo

Spectral Medical Inc.

Winning the Battle Against Endotoxic Septic Shock

38 employees · est. 1991 · Toronto, Canada

Spectral Medical Inc. is the older company (2016 vs 1991); Spectral Medical Inc. is the larger of the two.

Side-by-Side Comparison

Opticyte Spectral Medical Inc.
Founded
2016 1991 older
Headquarters
Seattle, United States Toronto, Canada
Employees
8 38 larger
Industry
Medical Devices Biotechnology, Health Care, Health and Wellness
Funding Stage
Non Equity Assistance IPO
Total Funding
$5.70M $65.88M
Funding Rounds
4 10
Services
Not tracked yet Endotoxin Activity Assay, Toraymyxin PMX Therapy, Biomedical Research and Innovation, Therapeutic Development for Sepsis, Clinical Trial Management
Target Customers
Not tracked yet Clinicians, Researchers, Hospitals and Healthcare Systems, Critical Care Specialists, Sepsis Patients
Taxonomy
Medical Device, Organ Failure Prevention, Sepsis, Continuous Monitoring, FDA Breakthrough Device Designation, Optical Spectroscopy, Multivariate Analysis, Clinical Data, Medical Device Commercialization, Cell O2 Monitor, Startup, Investment, Medical Technology, Healthcare Innovation, Seattle FDA Approval, Sepsis Treatment, Hemoperfusion Device, Endotoxin Removal, Diagnostic Testing, Clinical Trials, Breakthrough Device Designation
Website
opticyte.com spectraldx.com
Opticyte logo

About Opticyte

Opticyte is a cutting-edge medical device startup based in the United States, founded in 2016. The company's slogan, "Preventing Organ Failure Through Early Detection," underlines its dedication to transforming the standard of care for organ failure, particularly in cases such as sepsis, where the c...

Spectral Medical Inc. logo

About Spectral Medical Inc.

Spectral Medical Inc., founded in 1991 and headquartered in Canada, is at the forefront of combating endotoxic septic shock. The company’s innovative approach integrates the EAA™ Endotoxin Activity Assay and Toraymyxin™ (PMX) therapy. Their solution uniquely positions them in the Biotechnology and H...

We will tell you when either one moves

BounceWatch watches Opticyte and Spectral Medical Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Opticyte and Spectral Medical Inc. — by email.

Frequently Asked Questions

Opticyte — Preventing Organ Failure Through Early Detection. Join our crowdfunding campaign today on StartEngine!. Spectral Medical Inc. — Winning the Battle Against Endotoxic Septic Shock. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Opticyte has raised $5.70M while Spectral Medical Inc. has raised $65.88M.
Opticyte and Spectral Medical Inc. operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Opticyte with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Opticyte on 11 Sep 2024, and Spectral Medical Inc. on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes